Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An Open-Label Randomized Clinical Trial in Sub-Saharan Africa (DOXYCOV)

DOI record: { "DOI": "10.7759/cureus.45619", "ISSN": [ "2168-8184" ], "URL": "http://dx.doi.org/10.7759/cureus.45619", "author": [ { "affiliation": [], "family": "Sobngwi", "given": "Eugene", "sequence": "first" }, { "affiliation": [], "family": "Zemsi", "given": "Sylvain", "sequence": "additional" }, { "affiliation": [], "family": "Guewo", "given": "Magellan", "sequence": "additional" }, { "affiliation": [], "family": "Katte", "given": "Jean-Claude", "sequence": "additional" }, { "affiliation": [], "family": "Kouanfack", "given": "Charles", "sequence": "additional" }, { "affiliation": [], "family": "Mfeukeu", "given": "Liliane", "sequence": "additional" }, { "affiliation": [], "family": "Zemsi", "given": "Armel", "sequence": "additional" }, { "affiliation": [], "family": "Wasnyo", "given": "Yves", "sequence": "additional" }, { "affiliation": [], "family": "Ntsama Assiga", "given": "Antoinette", "sequence": "additional" }, { "affiliation": [], "family": "Ndi Manga", "given": "Arnaud", "sequence": "additional" }, { "affiliation": [], "family": "Sobngwi-Tambekou", "given": "Joelle", "sequence": "additional" }, { "affiliation": [], "family": "Ngatchou", "given": "William", "sequence": "additional" }, { "affiliation": [], "family": "Moussi Omgba", "given": "Charlotte", "sequence": "additional" }, { "affiliation": [], "family": "Mbanya", "given": "Jean-Claude", "sequence": "additional" }, { "affiliation": [], "family": "Ongolo Zogo", "given": "Pierre", "sequence": "additional" }, { "affiliation": [], "family": "Fouda", "given": "Pierre Joseph", "sequence": "additional" } ], "container-title": "Cureus", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2023, 9, 20 ] ], "date-time": "2023-09-20T16:44:45Z", "timestamp": 1695228285000 }, "deposited": { "date-parts": [ [ 2023, 9, 20 ] ], "date-time": "2023-09-20T16:44:50Z", "timestamp": 1695228290000 }, "indexed": { "date-parts": [ [ 2023, 9, 21 ] ], "date-time": "2023-09-21T05:51:19Z", "timestamp": 1695275479057 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2023, 9, 20 ] ] }, "language": "en", "link": [ { "URL": "https://www.cureus.com/articles/179159-doxycycline-vs-hydroxychloroquine--azithromycin-in-the-management-of-covid-19-patients-an-open-label-randomized-clinical-trial-in-sub-saharan-africa-doxycov", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.7759", "published": { "date-parts": [ [ 2023, 9, 20 ] ] }, "published-print": { "date-parts": [ [ 2023, 9, 20 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1186/s13063-020-04352-9", "article-title": "Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial", "author": "Wang Y", "doi-asserted-by": "publisher", "journal-title": "Trials", "key": "ref1", "unstructured": "Wang Y, Zhou F, Zhang D, et al.. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020, 21:422. 10.1186/s13063-020-04352-9", "volume": "21", "year": "2020" }, { "DOI": "10.1016/j.ejphar.2021.173890", "article-title": "A review of potential suggested drugs for coronavirus disease (COVID-19) treatment", "author": "Tarighi P", "doi-asserted-by": "publisher", "journal-title": "Eur J Pharmacol", "key": "ref2", "unstructured": "Tarighi P, Eftekhari S, Chizari M, Sabernavaei M, Jafari D, Mirzabeigi P. A review of potential suggested drugs for coronavirus disease (COVID-19) treatment. Eur J Pharmacol. 2021, 895:173890. 10.1016/j.ejphar.2021.173890", "volume": "895", "year": "2021" }, { "DOI": "10.1001/jamacardio.2020.1834", "article-title": "Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)", "author": "Mercuro NJ", "doi-asserted-by": "publisher", "journal-title": "JAMA Cardiol", "key": "ref3", "unstructured": "Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, Gold HS. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020, 5:1036-41. 10.1001/jamacardio.2020.1834", "volume": "5", "year": "2020" }, { "DOI": "10.2165/00003495-199244020-00005", "article-title": "Effective treatment of urethritis. A practical guide", "author": "Bowie WR", "doi-asserted-by": "publisher", "journal-title": "Drugs", "key": "ref4", "unstructured": "Bowie WR. Effective treatment of urethritis. A practical guide. Drugs. 1992, 44:207-15. 10.2165/00003495-199244020-00005", "volume": "44", "year": "1992" }, { "DOI": "10.1111/j.1749-6632.2011.06354.x", "article-title": "The history of the tetracyclines", "author": "Nelson ML", "doi-asserted-by": "publisher", "journal-title": "Ann N Y Acad Sci", "key": "ref5", "unstructured": "Nelson ML, Levy SB. The history of the tetracyclines. Ann N Y Acad Sci. 2011, 1241:17-32. 10.1111/j.1749-6632.2011.06354.x", "volume": "1241", "year": "2011" }, { "DOI": "10.1016/j.idcr.2020.e00864", "article-title": "Doxycycline as a potential partner of COVID-19 therapies", "author": "Malek AE", "doi-asserted-by": "publisher", "journal-title": "IDCases", "key": "ref6", "unstructured": "Malek AE, Granwehr BP, Kontoyiannis DP. Doxycycline as a potential partner of COVID-19 therapies. IDCases. 2020, 21:e00864. 10.1016/j.idcr.2020.e00864", "volume": "21", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105949", "article-title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial", "author": "Gautret P", "doi-asserted-by": "publisher", "journal-title": "Int J Antimicrob Agents", "key": "ref7", "unstructured": "Gautret P, Lagier JC, Parola P, et al.. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020, 56:105949. 10.1016/j.ijantimicag.2020.105949", "volume": "56", "year": "2020" }, { "DOI": "10.4269/ajtmh.20-0290", "article-title": "Chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19 in Africa: caution for inappropriate off-label use in healthcare settings", "author": "Abena PM", "doi-asserted-by": "publisher", "journal-title": "Am J Trop Med Hyg", "key": "ref8", "unstructured": "Abena PM, Decloedt EH, Bottieau E, et al.. Chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19 in Africa: caution for inappropriate off-label use in healthcare settings. Am J Trop Med Hyg. 2020, 102:1184-8. 10.4269/ajtmh.20-0290", "volume": "102", "year": "2020" }, { "DOI": "10.1007/s00705-013-1880-7", "article-title": "Inhibitory effect of doxycycline against dengue virus replication in vitro", "author": "Rothan HA", "doi-asserted-by": "publisher", "journal-title": "Arch Virol", "key": "ref9", "unstructured": "Rothan HA, Mohamed Z, Paydar M, Rahman NA, Yusof R. Inhibitory effect of doxycycline against dengue virus replication in vitro. Arch Virol. 2014, 159:711-8. 10.1007/s00705-013-1880-7", "volume": "159", "year": "2014" }, { "key": "ref10", "unstructured": "Lu K. Cochran-Mantel-Haenszel Weighted Miettinen & Nurminen Method for Confidence Intervals of the Difference in Binomial Proportions from Stratified 2x2 Samples. (2008). https.//www.markstat.net/en/images/stories/lu_asa_2008.pdf." }, { "DOI": "10.7759/cureus.9658", "article-title": "Clinical outcomes of early treatment with doxycycline for 89 high-risk COVID-19 patients in long-term care facilities in New York", "author": "Alam MM", "doi-asserted-by": "publisher", "journal-title": "Cureus", "key": "ref11", "unstructured": "Alam MM, Mahmud S, Rahman MM, Simpson J, Aggarwal S, Ahmed Z. Clinical outcomes of early treatment with doxycycline for 89 high-risk COVID-19 patients in long-term care facilities in New York. Cureus. 2020, 12:e9658. 10.7759/cureus.9658", "volume": "12", "year": "2020" }, { "DOI": "10.4269/ajtmh.20-0262", "article-title": "Rigorous randomized controlled trial implementation in the era of COVID-19", "author": "Oldenburg CE", "doi-asserted-by": "publisher", "journal-title": "Am J Trop Med Hyg", "key": "ref12", "unstructured": "Oldenburg CE, Doan T. Rigorous randomized controlled trial implementation in the era of COVID-19. Am J Trop Med Hyg. 2020, 102:1154-5. 10.4269/ajtmh.20-0262", "volume": "102", "year": "2020" }, { "DOI": "10.1016/j.medmal.2020.03.006", "article-title": "No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection", "author": "Molina JM", "doi-asserted-by": "publisher", "journal-title": "Med Mal Infect", "key": "ref13", "unstructured": "Molina JM, Delaugerre C, Le Goff J, Mela-Lima B, Ponscarme D, Goldwirt L, de Castro N. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Med Mal Infect. 2020, 50:384. 10.1016/j.medmal.2020.03.006", "volume": "50", "year": "2020" }, { "article-title": "Doxycycline as a modulator of inflammation in chronic wounds", "author": "Wilcox JR", "journal-title": "Wounds", "key": "ref14", "unstructured": "Wilcox JR, Covington DS, Paez N. Doxycycline as a modulator of inflammation in chronic wounds. Wounds. 2012, 24:339-49.", "volume": "24", "year": "2012" }, { "key": "ref15", "unstructured": "National Institute of Health. COVID-19 Treatment Guidelines. Clinical Spectrum of SARS-CoV2 Infection. (2023). Accessed. March 6, 2023: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/." }, { "key": "ref16", "unstructured": "COVID-19. In Cameroon, the Raoult Method Established as a State Protocol. (2020). Accessed: August 19, 2023: https://www.france24.com/fr/20200502-covid-19-au-cameroun-la-m%C3%A9thode-raoult-%C3%A9rig%C3%A9e-en-protocole-d-%C3%...." }, { "DOI": "10.4236/wjcd.2021.112012", "article-title": "Electrocardiographic safety of daily hydroxychloroquine 400 mg plus azithromycin 250 mg as an ambulatory treatment for COVID-19 patients in Cameroon", "author": "Mfeukeu-Kuate L", "doi-asserted-by": "publisher", "journal-title": "World J Cardiovasc Dis", "key": "ref17", "unstructured": "Mfeukeu-Kuate L, Ngatchou WD, Temgoua MN, et al.. Electrocardiographic safety of daily hydroxychloroquine 400 mg plus azithromycin 250 mg as an ambulatory treatment for COVID-19 patients in Cameroon. World J Cardiovasc Dis. 2021, 11:106-12. 10.4236/wjcd.2021.112012", "volume": "11", "year": "2021" }, { "DOI": "10.7326/M20-4207", "article-title": "Hydroxychloroquine in nonhospitalized adults with early COVID-19: A randomized trial", "author": "Skipper CP", "doi-asserted-by": "publisher", "journal-title": "Ann Intern Med", "key": "ref18", "unstructured": "Skipper CP, Pastick KA, Engen NW, et al.. Hydroxychloroquine in nonhospitalized adults with early COVID-19: A randomized trial. Ann Intern Med. 2020, 173:623-31. 10.7326/M20-4207", "volume": "173", "year": "2020" }, { "DOI": "10.1111/all.14496", "article-title": "Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID‐19 patients", "author": "Zhang J", "doi-asserted-by": "publisher", "journal-title": "Allergy", "key": "ref19", "unstructured": "Zhang J, Cao Y, Tan G, et al.. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID‐19 patients. Allergy. 2021, 76:533-50. 10.1111/all.14496", "volume": "76", "year": "2021" }, { "key": "ref20", "unstructured": "Johns Hopkins Medecine. Coronavirus and COVID- 19. Younger Adults Are at Risk, Too. (2020). Accessed: August 19, 2023: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-and-covid-19-younger-adults-ar...." } ], "reference-count": 20, "references-count": 20, "relation": {}, "resource": { "primary": { "URL": "https://www.cureus.com/articles/179159-doxycycline-vs-hydroxychloroquine--azithromycin-in-the-management-of-covid-19-patients-an-open-label-randomized-clinical-trial-in-sub-saharan-africa-doxycov" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Aerospace Engineering" ], "subtitle": [], "title": "Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An Open-Label Randomized Clinical Trial in Sub-Saharan Africa (DOXYCOV)", "type": "journal-article" }